Viking Fund Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73M Hold
20,000
– – 0.15% 112
2026
Q2
$1.81M Hold
20,000
– – 0.16% 114
2026
Q1
$1.6M Hold
20,000
– – 0.16% 117
2025
Q4
$1.7M Hold
20,000
– – 0.2% 111
2025
Q3
$1.56M Hold
20,000
– – 0.19% 111
2025
Q2
$1.56M Hold
20,000
– – 0.21% 102
2025
Q1
$1.45M Hold
20,000
– – 0.21% 98
2024
Q4
$1.48M Hold
20,000
– – 0.23% 99
2024
Q3
$1.32M Hold
20,000
– – 0.21% 100
2024
Q2
$1.85M Hold
20,000
– – 0.33% 86
2024
Q1
$1.91M Hold
20,000
– – 0.35% 87
2023
Q4
$1.52M Hold
20,000
– – 0.3% 92
2023
Q3
$1.39M Hold
20,000
– – 0.28% 93
2023
Q2
$1.89M Hold
20,000
– – 0.36% 89
2023
Q1
$1.65M Hold
20,000
– – 0.32% 95
2022
Q4
$1.49M Hold
20,000
– – 0.3% 98
2022
Q3
$1.65M Hold
20,000
– – 0.39% 90
2022
Q2
$1.9M Hold
20,000
– – 0.44% 90
2022
Q1
$2.35M Hold
20,000
– – 0.54% 68
2021
Q4
$2.59M Hold
20,000
– – 0.68% 49
2021
Q3
$2.26M Hold
20,000
– – 0.66% 54
2021
Q2
$2.07M Hold
20,000
– – 0.59% 64
2021
Q1
$1.67M Buy
20,000
+11,000
+122% +$930K 0.5% 76
2020
Q4
$821K Hold
9,000
– – 0.26% 104
2020
Q3
$718K Hold
9,000
– – 0.27% 93
2020
Q2
$622K Hold
9,000
– – 0.23% 105
2020
Q1
$566K Hold
9,000
– – 0.25% 91
2019
Q4
$700K Hold
9,000
– – 0.2% 95
2019
Q3
$660K Hold
9,000
– – 0.19% 95
2019
Q2
$554K Hold
9,000
– – 0.15% 105
2019
Q1
$574K Hold
9,000
– – 0.14% 101
2018
Q4
$460K Buy
+9,000
New +$455K 0.13% 107

Other funds holding EW

Viking Fund Management's EW Position: Q3 2026 in Review

Viking Fund Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 20,000 shares worth $1.73M. The position accounts for 0.15% of the portfolio, ranked #112.

Viking Fund Management first reported a position in EW in Q4 2018 and has held it in 32 quarters since. The position peaked at $2.59M in Q4 2021. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Viking Fund Management held 20,000 shares of Edwards Lifesciences worth $1.73M as of Q3 2026.
  • Viking Fund Management left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.15% of Viking Fund Management's portfolio in Q3 2026, its #112 holding.
  • Viking Fund Management first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 32 quarters since.
  • Viking Fund Management's Edwards Lifesciences position peaked at $2.59M in Q4 2021.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Viking Fund Management's 13F filing for Q3 2026, filed 14 Oct 2026.